FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileRevvity, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RVTY
Revvity, Inc. Stock AnalysisComprehensive stock analysis for Revvity, Inc. (RVTY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRVTY
RVTY
Revvity, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RVTY
  1. Home
  2. Stocks
  3. Revvity, Inc.

Revvity, Inc.

🇺🇸RVTY•NYSE

Revvity, Inc.

🇺🇸RVTY•NYSE
Market cap
$16.62B
Sentiment

Your view on RVTY

Mkt Cap
$16.62B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Revvity, Inc.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Prahlad R. Singh
Headquarters
940 Winter Street, Waltham, MA, US
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Prahlad R. Singh
Headquarters
940 Winter Street, Waltham, MA, US
Description

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics.

The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.

It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil.

In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries.

The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.

This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery.

It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies.

The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Revvity, Inc. from FRC's valuation model, read against the market price. RVTY last traded at $148.85, 66.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Revvity, Inc.. Starting points for Revvity, Inc.: P/E 66.2, EPS $2.27, beta 1.08 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Revvity, Inc.. Revvity, Inc. paid $0.28 per share over the last year — a 0.2% yield at the current $148.85 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Revvity, Inc.. Trailing twelve-month EPS for Revvity, Inc. stands at $2.27. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Revvity, Inc.. Revvity, Inc. has reported as a listed company since 1965. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold RVTY12 companies

More Medical - Diagnostics & Research companies

Market cap

  • ANPCFCellbxhealth PLCOTC$4M
  • ARYCArrayit CorporationOTC$79,348
  • AVCR.VAvricore Health Inc.TSXV$3M
  • AVCRFAvricore Health Inc.OTC$6M
  • BDSXBiodesix, Inc.NASDAQ$73M
  • BDX.AXBCAL Diagnostics LimitedASX
  • BIAFbioAffinity Technologies, Inc.NASDAQ$13M
  • BIAFWbioAffinity Technologies, Inc.NASDAQ$5M
  • BIOCQBiocept, Inc.OTC$263
  • BIOQBioqual, Inc.OTC$34M
  • BLLNBillionToOne, Inc.NASDAQ$4.6B
  • BMKDFBioMark Diagnostics Inc.OTC$42M
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Revvity, Inc., and how their positions are changing. At a $16.62B market value, institutional positions materially move Revvity, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Revvity, Inc. executives and directors. Shares of Revvity, Inc. have traded between $81.36 and $128.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Revvity, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Revvity, Inc.. Coverage tracks Revvity, Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Revvity, Inc.

RVTY Analysis
Fair
Past4
Growth1
Health3
Profit1
Value1

News

Latest Market News